Citation: Rongquan Huang, Xusha Zhou, Shuqi Ren, Xianjie Liu, Zhiyuan Han, Grace Guoying Zhou. Effect of Loss-of-function of the Herpes Simplex Virus-1 microRNA H6-5p on Virus Replication .VIROLOGICA SINICA, 2019, 34(4) : 386-396.  http://dx.doi.org/10.1007/s12250-019-00111-6

Effect of Loss-of-function of the Herpes Simplex Virus-1 microRNA H6-5p on Virus Replication

cstr: 32224.14.s12250-019-00111-6
  • Corresponding author: Zhiyuan Han, zac_zhiyuan0420@126.com, ORCID: 0000-0001-6188-0433
    Grace Guoying Zhou, zhoug@siitm.org.cn, ORCID: 0000-0001-6188-0433
  • Received Date: 07 December 2018
    Accepted Date: 28 February 2019
    Published Date: 24 April 2019
    Available online: 01 August 2019
  • To date, 29 distinct microRNAs (miRNAs) have been reported to be expressed during herpes simplex virus infections. Sequence analysis of mature herpes simplex virus-1 (HSV-1) miRNAs revealed five sets of miRNAs that are complementary to each other: miR-H6-5p/H1-3p, miR-H6-3p/H1-5p, H2-5p/H14-3p, miR-H2-3p/H14-5p, and miR-H7/H27. However, the roles of individual miRNAs and consequences of this complementarity remain unclear. Here, we focus on two of these complementary miRNAs, miR-H6-5p and miR-H1-3p, using loss-of-function experiments in vitro and in a mouse model of infection using an miRNA sponge approach, including tandem multiplex artificial miRNA-binding sequences that do not match perfectly to the target miRNA inserted downstream of a green fluorescent protein reporter gene. Infection with recombinant virus expressing the miR-H6-5p sponge reduced viral protein levels and virus yield. Decreased accumulation of viral proteins was also observed at early stages of infection in the presence of both an miR-H6-5p inhibitor and plasmid-expressed miR-H1-3p. Moreover, establishment of latency and reactivation did not differ between the recombinant virus expressing the miR-H6-5p sponge and wild-type HSV-1. Taken together, these data suggest that miR-H6-5p has an as-yet-unidentified role in the early stages of viral infection, and its complement miR-H1-3p suppresses this role in later stages of infection. This report extends understanding of the roles of miRNAs in infection by herpes simplex viruses, supporting a model of infection in which the production of virus and its virulent effects are tightly controlled to maximize persistence in the host and population.

  • 加载中
  • 10.1007s12250-019-00111-6-ESM1.pdf
    1. Ackermann M, Braun DK, Pereira L, Roizman B (1984) Characterization of herpes simplex virus 1 alpha proteins 0, 4, and 27 with monoclonal antibodies. J Virol 52:108-118

    2. Aranda AM, Epstein AL (2015) Herpes simplex virus type 1 latency and reactivation: an update. Med Sci (Paris) 31:506-514
        doi: 10.1051/medsci/20153105012

    3. Bloom DC (2016) Alphaherpesvirus latency: a dynamic state of transcription and reactivation. Adv Virus Res 94:53-80
        doi: 10.1016/bs.aivir.2015.10.001

    4. Carter CJ (2011) Alzheimer's disease plaques and tangles: cemeteries of a pyrrhic victory of the immune defence network against herpes simplex infection at the expense of complement and inflammation-mediated neuronal destruction. Neurochem Int 58:301-320
        doi: 10.1016/j.neuint.2010.12.003

    5. Cui C, Griffiths A, Li G, Silva LM, Kramer MF, Gaasterland T (2006) Prediction and identification of herpes simplex virus 1-encoded microRNAs. J Virol 80:5499-5508
        doi: 10.1128/JVI.00200-06

    6. Cui Y, Yu H, Zheng X, Peng R, Wang Q, Zhou Y, Wang R, Wang J, Qu B, Shen N, Guo Q, Liu X, Wang C (2017) SENP7 potentiates cGAS activation by relieving SUMO-mediated inhibition of cytosolic DNA sensing. PLoS Pathog 13:e1006156
        doi: 10.1371/journal.ppat.1006156

    7. Du T, Zhou G, Roizman B (2011) HSV-1 gene expression from reactivated ganglia is disordered and concurrent with suppression of latency-associated transcript and miRNAs. Proc Natl Acad Sci USA 108:18820-18824
        doi: 10.1073/pnas.1117203108

    8. Du T, Han Z, Zhou G, Roizman B (2015) Patterns of accumulation of miRNAs encoded by herpes simplex virus during productive infection, latency, and on reactivation. Proc Natl Acad Sci USA 112:E49-55
        doi: 10.1073/pnas.1422657112

    9. Ebert MS, Sharp PA (2010) MicroRNA sponges: progress and possibilities. RNA 16:2043-2050
        doi: 10.1261/rna.2414110

    10. Ejercito PM, Kieff ED, Roizman B (1968) Characterization of herpes simplex virus strains differing in their effects on social behaviour of infected cells. J Gen Virol 2:357-364
        doi: 10.1099/0022-1317-2-3-357

    11. Enk J, Levi A, Weisblum Y, Yamin R, Charpak-Amikam Y, Wolf DG (2016) HSV1 MicroRNA modulation of GPI anchoring and downstream immune evasion. Cell Rep 17:949-956
        doi: 10.1016/j.celrep.2016.09.077

    12. Flores O, Nakayama S, Whisnant AW, Javanbakht H, Cullen BR, Bloom DC (2013) Mutational inactivation of herpes simplex virus 1 microRNAs identifies viral mRNA targets and reveals phenotypic effects in culture. J Virol 87:6589-6603
        doi: 10.1128/JVI.00504-13

    13. Gregory D, Hargett D, Holmes D, Money E, Bachenheimer SL (2004) Efficient replication by herpes simplex virus type 1 involves activation of the IkappaB kinase-IkappaB-p65 pathway. J Virol 78:13582-13590
        doi: 10.1128/JVI.78.24.13582-13590.2004

    14. Gu H, Roizman B (2007) Herpes simplex virus-infected cell protein 0 blocks the silencing of viral DNA by dissociating histone deacetylases from the CoREST-REST complex. Proc Natl Acad Sci USA 104:17134-17139
        doi: 10.1073/pnas.0707266104

    15. Han Z, Liu X, Chen X, Zhou X, Du T, Roizman B (2016) miR-H28 and miR-H29 expressed late in productive infection are exported and restrict HSV-1 replication and spread in recipient cells. Proc Natl Acad Sci USA 113:E894-901
        doi: 10.1073/pnas.1525674113

    16. Horwich MD, Zamore PD (2008) Design and delivery of antisense oligonucleotides to block microRNA function in cultured drosophila and human cells. Nat Protoc 3:1537-1549
        doi: 10.1038/nprot.2008.145

    17. Jiang X, Brown D, Osorio N, Hsiang C, BenMohamed L, Wechsler SL (2016) Increased neurovirulence and reactivation of the herpes simplex virus type 1 latency-associated transcript (LAT)-negative mutant dLAT2903 with a disrupted LAT miR-H2. J Neurovirol 22:38-49
        doi: 10.1007/s13365-015-0362-y

    18. Jurak I, Kramer MF, Mellor JC, van Lint AL, Roth FP, Knipe DM (2010) Numerous conserved and divergent microRNAs expressed by herpes simplex viruses 1 and 2. J Virol 84:4659-4672
        doi: 10.1128/JVI.02725-09

    19. Jurak I, Hackenberg M, Kim JY, Pesola JM, Everett RD, Preston CM (2014) Expression of herpes simplex virus 1 microRNAs in cell culture models of quiescent and latent infection. J Virol 88:2337-2339
        doi: 10.1128/JVI.03486-13

    20. Kim H, Iizasa H, Kanehiro Y, Fekadu S, Yoshiyama H (2017) Herpesviral microRNAs in cellular metabolism and immune responses. Front Microbiol 8:1318
        doi: 10.3389/fmicb.2017.01318

    21. Kluiver J, Slezak-Prochazka I, Smigielska-Czepiel K, Halsema N, Kroesen BJ, van den Berg A (2012) Generation of miRNA sponge constructs. Methods 58:113-117
        doi: 10.1016/j.ymeth.2012.07.019

    22. Kramer MF, Jurak I, Pesola JM, Boissel S, Knipe DM, Coen DM (2011) Herpes simplex virus 1 microRNAs expressed abundantly during latent infection are not essential for latency in mouse trigeminal ganglia. Virology 417:239-247
        doi: 10.1016/j.virol.2011.06.027

    23. Kurata JS, Lin RJ (2018) MicroRNA-focused CRISPR-Cas9 library screen reveals fitness-associated miRNAs. RNA 24:966-981
        doi: 10.1261/rna.066282.118

    24. Liu Z, Sall A, Yang D (2008) MicroRNA: an emerging therapeutic target and intervention tool. Int J Mol Sci 9:978-999
        doi: 10.3390/ijms9060978

    25. Mallon S, Wakim BT, Roizman B (2012) Use of biotinylated plasmid DNA as a surrogate for HSV DNA to identify proteins that repress or activate viral gene expression. Proc Natl Acad Sci USA 109:E3549-3557

    26. Martinez-Torres FJ, Völcker D, Dörner N, Lenhard T, Nielsen S, Haas J, Kiening K, Meyding-Lamadé U (2007) Aquaporin 4 regulation during acute and long-term experimental Herpes simplex virus encephalitis. J Neurovirol 13:38-46
        doi: 10.1080/13550280601145340

    27. McKnight JL, Kristie TM, Roizman B (1987) Binding of the virion protein mediating alpha gene induction in herpes simplex virus 1-infected cells to its cis site requires cellular proteins. Proc Natl Acad Sci USA 84:7061-7065
        doi: 10.1073/pnas.84.20.7061

    28. Munson DJ, Burch AD (2012) A novel miRNA produced during lytic HSV-1 infection is important for efficient replication in tissue culture. Arch Virol 157:1677-1688
        doi: 10.1007/s00705-012-1345-4

    29. Roizman B, Whitley RJ (2013) An inquiry into the molecular basis of HSV latency and reactivation. Annu Rev Microbiol 67:355-374
        doi: 10.1146/annurev-micro-092412-155654

    30. Roller RJ, Roizman B (1992) The herpes simplex virus 1 RNA binding protein US11 is a virion component and associates with ribosomal 60S subunits. J Virol 66:3624-3632

    31. Sun L, Li Q (2012) The miRNAs of herpes simplex virus (HSV). Virol Sin 27:333-338

    32. Tay FC, Lim JK, Zhu H, Hin LC, Wang S (2015) Using artificial microRNA sponges to achieve microRNA loss-of-function in cancer cells. Adv Drug Deliv Rev 81:117-127
        doi: 10.1016/j.addr.2014.05.010

    33. Umbach JL, Kramer MF, Jurak I, Karnowski HW, Coen DM, Cullen BR (2008) MicroRNAs expressed by herpes simplex virus 1 during latent infection regulate viral mRNAs. Nature 454:780-783
        doi: 10.1038/nature07103

    34. Umbach JL, Nagel MA, Cohrs RJ, Gilden DH, Cullen BR (2009) Analysis of human alphaherpesvirus microRNA expression in latently infected human trigeminal ganglia. J Virol 83:10677-10683
        doi: 10.1128/JVI.01185-09

    35. Wang S, Mott KR, Cilluffo M, Kilpatrick CL, Murakami S, Ljubimov AV, Kousoulas KG, Awasthi S, Luscher B, Ghiasi H (2018) The absence of DHHC3 affects primary and latent herpes simplex virus 1 infection. J Virol 92:e01599-17

    36. Wu W, Guo Z, Zhang X, Guo L, Liu L, Liao Y (2013) A microRNA encoded by HSV-1 inhibits a cellular transcriptional repressor of viral immediate early and early genes. Sci China Life Sci 56:373-383
        doi: 10.1007/s11427-013-4458-4

    37. Yu X, He S (2016) The interplay between human herpes simplex virus infection and the apoptosis and necroptosis cell death pathways. Virol J 13:77
        doi: 10.1186/s12985-016-0528-0

    38. Zhao H, Zhang C, Hou G, Song J (2015) MicroRNA-H4-5p encoded by HSV-1 latency-associated transcript promotes cell proliferation, invasion and cell cycle progression via p16-mediated PI3 K-Akt signaling pathway in SHSY5Y cells. Int J Clin Exp Med 8:7526-7534

  • 加载中

Figures(6)

Article Metrics

Article views(9948) PDF downloads(52) Cited by()

Related
Proportional views

    Effect of Loss-of-function of the Herpes Simplex Virus-1 microRNA H6-5p on Virus Replication

      Corresponding author: Zhiyuan Han, zac_zhiyuan0420@126.com
      Corresponding author: Grace Guoying Zhou, zhoug@siitm.org.cn
    • 1. School of Basic Medical Sciences, Guangzhou Medical University, Guangzhou 511436, China
    • 2. Shenzhen International Institute for Biomedical Research, Shenzhen 518116, China

    Abstract: To date, 29 distinct microRNAs (miRNAs) have been reported to be expressed during herpes simplex virus infections. Sequence analysis of mature herpes simplex virus-1 (HSV-1) miRNAs revealed five sets of miRNAs that are complementary to each other: miR-H6-5p/H1-3p, miR-H6-3p/H1-5p, H2-5p/H14-3p, miR-H2-3p/H14-5p, and miR-H7/H27. However, the roles of individual miRNAs and consequences of this complementarity remain unclear. Here, we focus on two of these complementary miRNAs, miR-H6-5p and miR-H1-3p, using loss-of-function experiments in vitro and in a mouse model of infection using an miRNA sponge approach, including tandem multiplex artificial miRNA-binding sequences that do not match perfectly to the target miRNA inserted downstream of a green fluorescent protein reporter gene. Infection with recombinant virus expressing the miR-H6-5p sponge reduced viral protein levels and virus yield. Decreased accumulation of viral proteins was also observed at early stages of infection in the presence of both an miR-H6-5p inhibitor and plasmid-expressed miR-H1-3p. Moreover, establishment of latency and reactivation did not differ between the recombinant virus expressing the miR-H6-5p sponge and wild-type HSV-1. Taken together, these data suggest that miR-H6-5p has an as-yet-unidentified role in the early stages of viral infection, and its complement miR-H1-3p suppresses this role in later stages of infection. This report extends understanding of the roles of miRNAs in infection by herpes simplex viruses, supporting a model of infection in which the production of virus and its virulent effects are tightly controlled to maximize persistence in the host and population.